MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Movement disorders as a clinical feature of Subacute Sclerosing Pan Encephalitis: Expansion of phenotypic spectrum

D. Dash, M. Tripathi, R. Singh (Delhi, India)

Meeting: 2019 International Congress

Abstract Number: 701

Keywords: Bradykinesia

Session Information

Date: Monday, September 23, 2019

Session Title: Other

Session Time: 1:45pm-3:15pm

Location: Agora 2 West, Level 2

Objective: To study the frequency of movement Disorders(MD) in patients with Subacute Sclerosing Pan Encephalitis (SSPE). To describe the various type of MD in patients with SSPE To correlate imaging findings with the phenomenology of MD

Background: Subacute sclerosing panencephalitis (SSPE) is a rare, progressive complication of measles characterized by cognitive and motor deterioration, with death typically occurring within 1–3 years of symptom onset. Movement disorders are rarely part of the clinical features of patients with SSPE. We report 13 patients of SSPE who presented with movement disorders along with cognitive dysfunction in our centre. We studied the movement disorder phenomenology, clinical features, radiological features, treatment given in these 13 patients

Method: We prospectively screened consecutive patients with diagnosis of SSPE from our clinic and completed detailed history and examination over a period of six months. Of the 106 patients, 13 patients had movement disorders as a part of their clinical presentation. We recorded video of these patients and staged each patient according to Jabbour staging. We also recorded the various movement disorders encountered in structured proforma. We also evaluated the EEG findings and Neuroimaging findings and tried to correlate it with the type of movement disorder.

Results: The mean age of patients ranged from 7-17 years with mean age of 12.88 ± 0.992 years. There were 8 males and 5 females. Of the 13 patients, 12 had myoclonus, 8 had dystonia, 5 had Parkinsonism, 4 had tremor and 2 had stereotypies. When Jabbour staging was applied 3 were in stage 1, 4 in stage 3 and rest in stage 2.All the patients were given intrathecal α-interferon whereas 5 patients also were on Isosprinosine. Four of the five patients who had Parkinsonism had frontal white matter signal changes on MRI brain. Symptomatic treatment in the form of levodopa, trihexiphenydyl, levetiracetam was also given to patients.

Conclusion: Movement disorders can be an important clinical feature of patients with SSPE. Movement disorder specialists should keep a possibility of this devastating disorder in patients presenting with rapid cognitive decline along with movement disorders.

To cite this abstract in AMA style:

D. Dash, M. Tripathi, R. Singh. Movement disorders as a clinical feature of Subacute Sclerosing Pan Encephalitis: Expansion of phenotypic spectrum [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/movement-disorders-as-a-clinical-feature-of-subacute-sclerosing-pan-encephalitis-expansion-of-phenotypic-spectrum/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/movement-disorders-as-a-clinical-feature-of-subacute-sclerosing-pan-encephalitis-expansion-of-phenotypic-spectrum/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley